340 related articles for article (PubMed ID: 10706965)
1. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
[TBL] [Abstract][Full Text] [Related]
2. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
[TBL] [Abstract][Full Text] [Related]
3. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.
Van Herck K; Van Damme P; Collard F; Thoelen S
Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
[TBL] [Abstract][Full Text] [Related]
5. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
6. A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines.
Ramonet M; da Silveira TR; Lisker-Melman M; Rüttimann R; Pernambuco E; Cervantes Y; Cañero-Velasco MC; Falleiros-Carvalho LE; Azevedo T; Targa-Ferreira C; Clemens SA
Arch Med Res; 2002; 33(1):67-73. PubMed ID: 11825634
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
8. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
Van Der Wielen M; Van Damme P; Collard F
Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults.
Bruguera M; Bayas JM; Vilella A; Tural C; González A; Vidal J; Dal-Ré R; Salleras L
Vaccine; 1996 Oct; 14(15):1407-11. PubMed ID: 8994314
[TBL] [Abstract][Full Text] [Related]
10. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
11. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?
Kallinowski B; Knöll A; Lindner E; Sänger R; Stremmel W; Vollmar J; Zieger B; Jilg W
Vaccine; 2000 Aug; 19(1):16-22. PubMed ID: 10924782
[TBL] [Abstract][Full Text] [Related]
12. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine.
Ambrosch F; Wiedermann G; André FE; Delem A; Gregor H; Hofmann H; D'Hondt E; Kundi M; Wynen J; Kunz C
J Med Virol; 1994 Dec; 44(4):452-6. PubMed ID: 7897380
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous vaccination against hepatitis A and B: results of a controlled study.
Ambrosch F; André FE; Delem A; D'Hondt E; Jonas S; Kunz C; Safary A; Wiedermann G
Vaccine; 1992; 10 Suppl 1():S142-5. PubMed ID: 1335647
[TBL] [Abstract][Full Text] [Related]
15. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
16. A combined vaccine against hepatitis A and B in children and adolescents.
Diaz-Mitoma F; Law B; Parsons J
Pediatr Infect Dis J; 1999 Feb; 18(2):109-14. PubMed ID: 10048681
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and reactogenicity of a combined hepatitis A-hepatitis B vaccine in adolescents.
Thompson SC; Norris M
Int J Infect Dis; 1998; 2(4):193-6. PubMed ID: 9763500
[TBL] [Abstract][Full Text] [Related]
18. Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers.
Reutter J; Bart PA; Francioli P; Safary A; Frei PC
J Viral Hepat; 1998 May; 5(3):205-11. PubMed ID: 9658375
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults.
Leroux-Roels G; Moreau W; Desombere I; Safary A
Scand J Gastroenterol; 1996 Oct; 31(10):1027-31. PubMed ID: 8898425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
